Update on the prevention and treatment of endophthalmitis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.

Original languageEnglish
Pages (from-to)425-430
Number of pages6
JournalExpert Review of Ophthalmology
Volume9
Issue number5
DOIs
StatePublished - Jan 1 2014

Fingerprint

Endophthalmitis
Antibiotics
Polymerase chain reaction
Surgery
Anti-Bacterial Agents
Intravitreal Injections
Ceftazidime
Temazepam
Vitrectomy
Vancomycin
Therapeutics
Cataract
Polymerase Chain Reaction

Keywords

  • antibiotics
  • endophthalmitis
  • intravitreal injection
  • pars plana vitrectomy
  • polymerase chain reaction

ASJC Scopus subject areas

  • Ophthalmology
  • Biomedical Engineering
  • Optometry

Cite this

Update on the prevention and treatment of endophthalmitis. / Schwartz, Stephen; Flynn, Harry W.

In: Expert Review of Ophthalmology, Vol. 9, No. 5, 01.01.2014, p. 425-430.

Research output: Contribution to journalArticle

@article{d2d6cd61f4924bcca8d0c62176702bce,
title = "Update on the prevention and treatment of endophthalmitis",
abstract = "Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.",
keywords = "antibiotics, endophthalmitis, intravitreal injection, pars plana vitrectomy, polymerase chain reaction",
author = "Stephen Schwartz and Flynn, {Harry W}",
year = "2014",
month = "1",
day = "1",
doi = "10.1586/17469899.2014.951331",
language = "English",
volume = "9",
pages = "425--430",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Update on the prevention and treatment of endophthalmitis

AU - Schwartz, Stephen

AU - Flynn, Harry W

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.

AB - Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.

KW - antibiotics

KW - endophthalmitis

KW - intravitreal injection

KW - pars plana vitrectomy

KW - polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=84907204169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907204169&partnerID=8YFLogxK

U2 - 10.1586/17469899.2014.951331

DO - 10.1586/17469899.2014.951331

M3 - Article

VL - 9

SP - 425

EP - 430

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 5

ER -